Literature DB >> 3804983

Management of antidepressant-induced side effects: a practical guide for the clinician.

M H Pollack, J F Rosenbaum.   

Abstract

The treatment of antidepressant-induced side effects is an important area of clinical concern. Attention to the untoward consequences of pharmacotherapy improves patient compliance and allows the physician to treat patients with the appropriate medication at an efficacious dosage. Based upon review of the literature and clinical experience, a general guide is offered to help the clinician determine treatment strategies that may be effective in dealing with some of the more commonly encountered side effects of the heterocyclic antidepressants and monoamine oxidase inhibitors.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3804983

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  10 in total

Review 1.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

2.  Management of resistant depression.

Authors:  L Warneke
Journal:  Can Fam Physician       Date:  1996-10       Impact factor: 3.275

3.  The relationship of isolated sleep paralysis and panic disorder to hypertension.

Authors:  C C Bell; C J Hildreth; E J Jenkins; C Carter
Journal:  J Natl Med Assoc       Date:  1988-03       Impact factor: 1.798

Review 4.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Symptoms of major depression and tricyclic side effects in primary care patients.

Authors:  B L Rollman; M R Block; H C Schulberg
Journal:  J Gen Intern Med       Date:  1997-05       Impact factor: 5.128

6.  Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.

Authors:  B Spring; A J Gelenberg; R Garvin; S Thompson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat.

Authors:  K A Cunningham; P M Callahan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 8.  Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Nieves Prieto; Rubén de Alarcón; Nerea Casado-Espada; Javier de la Iglesia; Laura Montejo
Journal:  J Clin Med       Date:  2019-10-07       Impact factor: 4.241

9.  OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females.

Authors:  Mitchell F Brin; Suresh Durgam; Arlene Lum; Lynn James; Jeen Liu; Michael E Thase; Armin Szegedi
Journal:  Int Clin Psychopharmacol       Date:  2020-01       Impact factor: 2.023

10.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.